Personalized prediction for a 63 year old man who takes Rosuvastatin Calcium, Irbesartan (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 25,327 Rosuvastatin calcium users. Check the latest studies of Rosuvastatin calcium.
Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,405 Irbesartan users. Check the latest studies of Irbesartan.

What are the conditions?

High cholesterol is found to be associated with 3,205 drugs and 3,623 conditions by eHealthMe. Check the latest studies of High cholesterol.
High blood pressure is found to be associated with 3,502 drugs and 5,218 conditions by eHealthMe. Check the latest studies of High blood pressure.

What are the symtoms?

Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously) is found to be associated with 945 drugs and 939 conditions by eHealthMe. Check the latest studies of Polyneuropathy.

Potential side effects:

Dyspnea

5.13% for males aged 63 (±5) who have high blood pressure

High blood pressure

5.91% for males aged 63 (±5) who have high blood pressure

Muscle aches

5.96% for males aged 63 (±5) who have high cholesterol

Polyneuropathy

100.0% for males aged 63 (±5) who take rosuvastatin calcium and irbesartan and have polyneuropathy
100.0% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Weakness

5.07% for males aged 63 (±5) who have high cholesterol

Potential co-existing conditions:

Arrhythmias

6.45% for males aged 63 (±5) who have polyneuropathy with high blood pressure

Asthma

13.01% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Atrial fibrillation/flutter

5.38% for males aged 63 (±5) who have polyneuropathy with high blood pressure

Blood glucose abnormal

10.64% for males aged 63 (±5) who have polyneuropathy with high cholesterol

Cardiac disorder

5.23% for males aged 63 (±5) who have high cholesterol

Chronic obstructive pulmonary disease

8.13% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Colorectal cancer metastatic

13.01% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Dehydration

10.64% for males aged 63 (±5) who have polyneuropathy with high cholesterol

Depression

8.13% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Diabetes

11.65% for males aged 63 (±5) who have high cholesterol and high blood pressure

Diarrhea

8.13% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Enlarged prostate

6.5% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Gastric ulcer

5.38% for males aged 63 (±5) who have polyneuropathy with high blood pressure

Hyperlipidaemia

5.22% for males aged 63 (±5) who have high blood pressure

Hyperuricaemia

5.69% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Leukopenia

6.45% for males aged 63 (±5) who have polyneuropathy with high blood pressure

Lung cancer - non-small cell

6.45% for males aged 63 (±5) who have polyneuropathy with high blood pressure

Multiple myeloma

12.59% for males aged 63 (±5) who take rosuvastatin calcium and irbesartan and have polyneuropathy

Muscle relaxant therapy

10.64% for males aged 63 (±5) who have polyneuropathy with high cholesterol

Nausea

8.13% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Neuralgia

5.69% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Non-hodgkin's lymphoma

14.63% for males aged 63 (±5) who have polyneuropathy with high cholesterol and high blood pressure

Parkinson's disease

5.59% for males aged 63 (±5) who take rosuvastatin calcium and irbesartan and have polyneuropathy

Rashes

5.38% for males aged 63 (±5) who have polyneuropathy with high blood pressure

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.